498 related articles for article (PubMed ID: 22241157)
21. [Amyloidosis associated with IGD (lambda) myeloma in a Hansen's disease patient].
Feyeux C; Verola O; Bakir R; Rouffy J
Ann Dermatol Venereol; 1983; 110(9):717-8. PubMed ID: 6419662
[No Abstract] [Full Text] [Related]
22. [IgD myeloma: an aggressive variant. Description of a clinical case and review of the literature].
Airoldi M; Pelucco L; Lamperti R; Gioia F
Recenti Prog Med; 1993 Jun; 84(6):423-7. PubMed ID: 8516549
[TBL] [Abstract][Full Text] [Related]
23. Multiple myeloma with monoclonal IgG and IgD of lambda type exhibiting, under treatment, a shift from mainly IgG to mainly IgD.
Gallart T; Bladé J; Martínez-Quesada J; Sierra J; Rozman C; Vives J
Immunology; 1985 May; 55(1):45-57. PubMed ID: 3922877
[TBL] [Abstract][Full Text] [Related]
24. [Immunoglobulin D lambda multiple myeloma: a case report].
Qiao SK; Zhang XJ; Wang FX; Pan L; Yao L; Dong ZR
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Jun; 15(3):643-6. PubMed ID: 17605885
[TBL] [Abstract][Full Text] [Related]
25. A case of IgD myeloma representing a missed biclonal paraproteinemia or isotype switch in a patient previously diagnosed with IgA-lambda myeloma.
Chepovetsky J; Chari A; Jagannath S; Ramanthan L
Clin Chim Acta; 2013 Oct; 425():233-5. PubMed ID: 23954772
[TBL] [Abstract][Full Text] [Related]
26. Immunoglobulin D lambda multiple myeloma and amyloidosis with predominant soft tissue involvement.
Bahat G; Erten N; Saka B; Uzun S; Onur I; Kalayoglu-Besisik S; Buyukbabani N
Amyloid; 2007 Dec; 14(4):305-8. PubMed ID: 17968692
[TBL] [Abstract][Full Text] [Related]
27. IgD-λ multiple myeloma with excessive excretion of free light chains: a diagnostic trap in the identification of monoclonal gammopathies.
Zahir H; Tali A; Rachidi M; Mouhib H; Daif H; Ait Ouzdi Z; Haouach K; Chabaa L
Ann Biol Clin (Paris); 2019 Feb; 77(1):107-111. PubMed ID: 30799291
[TBL] [Abstract][Full Text] [Related]
28. [Coma, hyperviscosity syndrome, hyperammonemia and myelofibrosis in a patient with IgG, lambda type multiple myeloma].
Tsunoda S; Sasaki R; Miwa A; Sakurabayashi I; Miura Y
Rinsho Ketsueki; 1989 Mar; 30(3):361-5. PubMed ID: 2504973
[TBL] [Abstract][Full Text] [Related]
29. Extensive haemorrhagic-bullous skin manifestation of systemic AA-amyloidosis associated with IgGlambda-myeloma.
Grundmann JU; Bonnekoh B; Gollnick H
Eur J Dermatol; 2000 Mar; 10(2):139-42. PubMed ID: 10694315
[TBL] [Abstract][Full Text] [Related]
30. Low grade multiple myeloma that presented as a labial swelling -- a case report.
Ariyaratnam S; Sweet C; Duxbury J
Br Dent J; 2005 Oct; 199(7):433-5. PubMed ID: 16215569
[TBL] [Abstract][Full Text] [Related]
31. IgD myeloma: clinical, biological and laboratory features.
Sinclair D
Clin Lab; 2002; 48(11-12):617-22. PubMed ID: 12465746
[TBL] [Abstract][Full Text] [Related]
32. Best treatment strategies in high-risk multiple myeloma: navigating a gray area.
Bianchi G; Richardson PG; Anderson KC
J Clin Oncol; 2014 Jul; 32(20):2125-32. PubMed ID: 24888801
[TBL] [Abstract][Full Text] [Related]
33. [A case report of IgD myeloma with acute renal failure and deposition of lambda light chain along the tubular basement membrane].
Takeda A; Morozumi K; Yoshida A; Suganuma T; Satoh K; Oikawa T; Fujinami T; Sigematsu H
Nihon Jinzo Gakkai Shi; 1989 Mar; 31(3):259-66. PubMed ID: 2500549
[TBL] [Abstract][Full Text] [Related]
34. [A patient with AL amyloidosis and severe factor X deficiency has been in complete haematological remission with normal factor X activity for 7 years following high-dose chemotherapy. A case study and literature review].
Adam Z; Matýková M; Krejcí M; Pour L; Kissová J; Slechtová M; Chlupová G; Stavarová Y; Simonides J; Penka M; Mayer J; Hájek R
Vnitr Lek; 2010 Jan; 56(1):67-78. PubMed ID: 20184115
[TBL] [Abstract][Full Text] [Related]
35. Primary systemic amyloidosis: three different presentations.
Saoji V; Chaudhari S; Gohokar D
Indian J Dermatol Venereol Leprol; 2009; 75(4):394-7. PubMed ID: 19584467
[TBL] [Abstract][Full Text] [Related]
36. [Severe gastrointestinal bleeding, arthralgia and peripheral neuropathy in a patient with Bence Jones protein lambda multiple myeloma associated with systemic amyloidosis].
Iijima S; Ko K; Nishinarita S; Sawada S; Okayasu M; Fukuchi H; Nishikawa T; Murayama I; Kodama M; Miyakawa K
Rinsho Ketsueki; 1987 Aug; 28(8):1430-5. PubMed ID: 2828717
[No Abstract] [Full Text] [Related]
37. Amyloid arthropathy resembling seronegative rheumatoid arthritis in a patient with IgD-kappa multiple myeloma.
Fujishima M; Komatsuda A; Imai H; Wakui H; Watanabe W; Sawada K
Intern Med; 2003 Jan; 42(1):121-4. PubMed ID: 12583633
[TBL] [Abstract][Full Text] [Related]
38. A case report of biclonal immunoglobulin D lambda/lambda multiple myeloma in patient with liver echinococcosis.
Prce A; Dunđerović Ž; Mikulić I; Mikulić V; Ljubić K; Ćuk A; Bogut A; Petrović J; Volarić M; Čolak T; Raguž F
Biochem Med (Zagreb); 2024 Jun; 34(2):020801. PubMed ID: 38665868
[TBL] [Abstract][Full Text] [Related]
39. A case of light chain (AL) amyloidosis associated with IgD multiple myeloma (MM): clinical features, laboratory findings and outcome.
Rizzi R; Miccolis R; Rinaldi E; Bonerba B; Rossini M; Manno C; Curci P; Specchia G; Liso V
Amyloid; 2011 Jun; 18 Suppl 1():117-8. PubMed ID: 21838455
[No Abstract] [Full Text] [Related]
40. [Improvement of hepatomegaly after treatment with autologous hematopoietic stem cell transplantation followed by bortezomib and dexamethasone in Bence-Jones protein κ-type of multiple myeloma with systemic amyloidosis].
Nagamachi Y; Yamauchi N; Muramatsu H; Miyajima N; Inomata H; Okamoto T; Nozawa E; Gotoh Y; Koyama R; Ihara K; Nishisato T; Kato J
Rinsho Ketsueki; 2015 Mar; 56(3):323-8. PubMed ID: 25876787
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
